Anthracyclines improve survival in HER2-positive breast cancer patients

[News]

Treatment with the class of chemotherapy drugs called anthracyclines improves survival in women with HER2-positive breast cancer who have previously had surgery, but it may not offer any benefit for women with HER2-negative tumors, according to a study published online December 25 in the Journal of the National Cancer Institute.

More... (http://www.news-medical.net/?id=33777)